Industry: Pharmaceuticals, Biotechnology
ViaCell is a biotechnology company focused on enabling the widespread use of human cells as medicine. The Company is developing a pipeline of proprietary stem cell product candidates intended to address cancer, cardiac disease, and diabetes. CB001, its lead cord blood derived stem cell therapy product candidate, is being developed for hematopoietic stem cell transplantation in patients affected by a variety of cancers. In addition to its therapeutic development programs, ViaCell’s reproductive health business unit commercializes ViaCord(R), a product that offers expecting families the option of preserving their baby’s umbilical cord ( www.viacellinc.com )
ViaCell , Inc.
245 First Street Fifteenth Floor
Cambridge, Massachusetts 02142
USA
Tel: (617) 914-3400
Fax: (617) 914-3794